The University of Chicago Header Logo

Connection

Robert Naclerio to Anti-Inflammatory Agents

This is a "connection" page, showing publications Robert Naclerio has written about Anti-Inflammatory Agents.
Connection Strength

1.834
  1. Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis. J Allergy Clin Immunol. 2011 Apr; 127(4):927-34.
    View in: PubMed
    Score: 0.323
  2. Treatment of nasal inflammation decreases the ability of subjects with asthma to condition inspired air. Am J Respir Crit Care Med. 2004 Oct 15; 170(8):863-9.
    View in: PubMed
    Score: 0.202
  3. A comparison of nasal clearance after treatment of perennial allergic rhinitis with budesonide and mometasone. Otolaryngol Head Neck Surg. 2003 Feb; 128(2):220-7.
    View in: PubMed
    Score: 0.185
  4. Absence of nasal mucosal atrophy with fluticasone aqueous nasal spray. Arch Otolaryngol Head Neck Surg. 2001 Feb; 127(2):193-9.
    View in: PubMed
    Score: 0.161
  5. Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis. Allergy. 2020 01; 75(1):148-157.
    View in: PubMed
    Score: 0.147
  6. Intranasal beclomethasone reduces allergen-induced symptoms and superficial mucosal eosinophilia without affecting submucosal inflammation. Am J Respir Crit Care Med. 1998 Mar; 157(3 Pt 1):899-906.
    View in: PubMed
    Score: 0.131
  7. Ragweed allergic rhinitis and the paranasal sinuses. A computed tomographic study. Arch Otolaryngol Head Neck Surg. 1997 Feb; 123(2):193-6.
    View in: PubMed
    Score: 0.122
  8. Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical Trial. JAMA. 2016 Feb 02; 315(5):469-79.
    View in: PubMed
    Score: 0.114
  9. Effect of prednisone on nasal symptoms and peripheral blood T-cell function in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2014 Aug; 4(8):609-16.
    View in: PubMed
    Score: 0.100
  10. The pathophysiology of allergic rhinitis: impact of therapeutic intervention. J Allergy Clin Immunol. 1988 Nov; 82(5 Pt 2):927-34.
    View in: PubMed
    Score: 0.069
  11. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. N Engl J Med. 1987 Jun 11; 316(24):1506-10.
    View in: PubMed
    Score: 0.062
  12. Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol. 2007 Jun; 119(6):1430-7.
    View in: PubMed
    Score: 0.062
  13. Fluticasone nasal spray and the combination of loratadine and montelukast in seasonal allergic rhinitis. Arch Otolaryngol Head Neck Surg. 2003 May; 129(5):557-62.
    View in: PubMed
    Score: 0.047
  14. Requirements for medications commonly used in the treatment of allergic rhinitis. European Academy of Allergy and Clinical Immunology (EAACI), Allergic Rhinitis and its Impact on Asthma (ARIA). Allergy. 2003 Mar; 58(3):192-7.
    View in: PubMed
    Score: 0.046
  15. Dose-dependent effects of intranasal steroids: how relevant? Ann Allergy Asthma Immunol. 2000 Oct; 85(4):248-9.
    View in: PubMed
    Score: 0.039
  16. Effect of the addition of montelukast to fluticasone propionate for the treatment of perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2010 Aug; 105(2):155-61.
    View in: PubMed
    Score: 0.019
  17. Is leukotriene B4 an important mediator in human IgE-mediated allergic reactions? Am Rev Respir Dis. 1987 Jun; 135(6 Pt 2):S42-5.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.